Who invested in SeLux Diagnostics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$48Mraised across 1 round since 2024, from 1 source

Latest round: Series D, $48MApr 2024
Investors: 4

See who backed them

The rounds

Apr 2024
Series D$48M
Source recordedSEC filing: $40M sold, first sale Feb 2024

Founders and team

From the SEC filings it signed: 7 on the team.

Adam Parker SteelExecutive Officeri
Aleksandar E. VacicExecutive Officeri
Eric E. SternExecutive Officer, Directori
Ingo Parker ChakravartyMr. Chakravarty was elected Director upon the Date of First Sale.i
John Parker WilsonExecutive Officeri
Michele Parker HealyExecutive Officeri
Steven E. LufkinExecutive Officer, Directori

On the board, as filediErich Parker SchellerJames Parker CassidyJamie Parker CondieOrhan Parker Gazelle

Everyone who backed them

RA Capital ManagementPrivate equity1round

National Institutes of HealthGovernment1round

Sands Capital VenturesPrivate equity1round

Northpond VenturesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about SeLux Diagnostics

Who invested in SeLux Diagnostics?

SeLux Diagnostics's investors include RA Capital Management, National Institutes of Health, Sands Capital Ventures and Northpond Ventures.

How much has SeLux Diagnostics raised?

SeLux Diagnostics has raised $48M across 1 round since 2024.

When did SeLux Diagnostics last raise?

SeLux Diagnostics's most recent round was a Series D of $48M in Apr 2024.

What was SeLux Diagnostics's biggest round?

Its most recent round, $48M in Apr 2024, is also its largest on record.

Who backed SeLux Diagnostics first?

SeLux Diagnostics's first round on record, in Apr 2024, was backed by RA Capital Management, National Institutes of Health and Sands Capital Ventures and 1 others.